Search research articles
Contact Us
Filters
Showing results (21-30 of 85) with videos related to
Page
of 9
Sort By:
Transplantation Proceedings
|
March 1, 2006
Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients
J Malyszko, J S Malyszko, T Hryszko, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1996
Erythropoietin and uremic platelet aggregation in vivo and in vitro
J S Malyszko, J Malyszko, K Pawlak, et al.
Transplantation Proceedings
|
October 8, 2003
Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients
J Malyszko, J S Malyszko, S Wolczynski, et al.
Thrombosis Research
|
February 1, 1995
Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats
A Azzadin, J Mysliwiec, T Wollny, et al.
Haemostasis
|
January 1, 1979
Vascular prostacyclin and plasminogen activator activity in experimental and clinical conditions of disturbed haemostasis or thrombosis
G de Gaetano, G Remuzzi, M Mysliwiec, et al.
International Urology and Nephrology
|
July 3, 2002
Accumulation of toxic products degradation of kynurenine in hemodialyzed patients
D Pawlak, K Pawlak, J Malyszko, et al.
Platelets
|
June 24, 2006
Modulation of hematopoiesis by ketanserin in erythropoietin-treated uremic patients: evidence from platelet studies
J Borawski, A Rydzewski, A Azzadin, et al.
Transplantation Proceedings
|
December 21, 2010
Kidney injury molecule-1 correlates with kidney function in renal allograft recipients
J Malyszko, E Koc-Zorawska, J S Malyszko, et al.
Advances in Medical Sciences
|
September 5, 2009
Tissue factor pathway inhibitor release and depletion by sulodexide in humans
J Borawski, J Gozdzikiewicz, M Dubowski, et al.
Transplantation Proceedings
|
December 23, 2008
Mast cells tryptase in patients after renal transplantation
M Barczyk, M Mysliwiec, M Kalinowski, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 85) with videos related to
Sort By:
Page
of 9
Transplantation Proceedings
|
March 1, 2006
Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients
J Malyszko, J S Malyszko, T Hryszko, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1996
Erythropoietin and uremic platelet aggregation in vivo and in vitro
J S Malyszko, J Malyszko, K Pawlak, et al.
Transplantation Proceedings
|
October 8, 2003
Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients
J Malyszko, J S Malyszko, S Wolczynski, et al.
Thrombosis Research
|
February 1, 1995
Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats
A Azzadin, J Mysliwiec, T Wollny, et al.
Haemostasis
|
January 1, 1979
Vascular prostacyclin and plasminogen activator activity in experimental and clinical conditions of disturbed haemostasis or thrombosis
G de Gaetano, G Remuzzi, M Mysliwiec, et al.
International Urology and Nephrology
|
July 3, 2002
Accumulation of toxic products degradation of kynurenine in hemodialyzed patients
D Pawlak, K Pawlak, J Malyszko, et al.
Platelets
|
June 24, 2006
Modulation of hematopoiesis by ketanserin in erythropoietin-treated uremic patients: evidence from platelet studies
J Borawski, A Rydzewski, A Azzadin, et al.
Transplantation Proceedings
|
December 21, 2010
Kidney injury molecule-1 correlates with kidney function in renal allograft recipients
J Malyszko, E Koc-Zorawska, J S Malyszko, et al.
Advances in Medical Sciences
|
September 5, 2009
Tissue factor pathway inhibitor release and depletion by sulodexide in humans
J Borawski, J Gozdzikiewicz, M Dubowski, et al.
Transplantation Proceedings
|
December 23, 2008
Mast cells tryptase in patients after renal transplantation
M Barczyk, M Mysliwiec, M Kalinowski, et al.
Page
of 9